Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 202

1.

Human cytomegalovirus pp71 stimulates major histocompatibility complex class i presentation of IE1-derived peptides at immediate early times of infection.

Hesse J, Reyda S, Tenzer S, Besold K, Reuter N, Krauter S, Büscher N, Stamminger T, Plachter B.

J Virol. 2013 May;87(9):5229-38. doi: 10.1128/JVI.03484-12. Epub 2013 Feb 28.

2.

Processing and MHC class I presentation of human cytomegalovirus pp65-derived peptides persist despite gpUS2-11-mediated immune evasion.

Besold K, Frankenberg N, Pepperl-Klindworth S, Kuball J, Theobald M, Hahn G, Plachter B.

J Gen Virol. 2007 May;88(Pt 5):1429-39.

PMID:
17412970
3.

Use of a lentiviral vector encoding a HCMV-chimeric IE1-pp65 protein for epitope identification in HLA-Transgenic mice and for ex vivo stimulation and expansion of CD8(+) cytotoxic T cells from human peripheral blood cells.

Rohrlich PS, Cardinaud S, Lulè J, Montero-Julian FA, Prodhomme V, Firat H, Davignon JL, Perret E, Monseaux S, Necker A, Michelson S, Lemonnier FA, Charneau P, Davrinche C.

Hum Immunol. 2004 May;65(5):514-22.

PMID:
15172452
5.

Exogenous introduction of an immunodominant peptide from the non-structural IE1 protein of human cytomegalovirus into the MHC class I presentation pathway by recombinant dense bodies.

Mersseman V, Besold K, Reddehase MJ, Wolfrum U, Strand D, Plachter B, Reyda S.

J Gen Virol. 2008 Feb;89(Pt 2):369-79. doi: 10.1099/vir.0.83380-0.

PMID:
18198367
6.

Suppression of CD8+ T-cell recognition in the immediate-early phase of human cytomegalovirus infection.

Hesse J, Ameres S, Besold K, Krauter S, Moosmann A, Plachter B.

J Gen Virol. 2013 Feb;94(Pt 2):376-86. doi: 10.1099/vir.0.045682-0. Epub 2012 Oct 24.

PMID:
23100361
7.

Presentation of an immunodominant immediate-early CD8+ T cell epitope resists human cytomegalovirus immunoevasion.

Ameres S, Mautner J, Schlott F, Neuenhahn M, Busch DH, Plachter B, Moosmann A.

PLoS Pathog. 2013;9(5):e1003383. doi: 10.1371/journal.ppat.1003383. Epub 2013 May 23.

8.

Analysis of the functional interchange between the IE1 and pp71 proteins of human cytomegalovirus and ICP0 of herpes simplex virus 1.

Lu Y, Everett RD.

J Virol. 2015 Mar;89(6):3062-75. doi: 10.1128/JVI.03480-14. Epub 2014 Dec 31.

9.

Identification of a conserved HLA-A2-restricted decapeptide from the IE1 protein (pUL123) of human cytomegalovirus.

Frankenberg N, Pepperl-Klindworth S, Meyer RG, Plachter B.

Virology. 2002 Apr 10;295(2):208-16.

10.

Immune evasion proteins gpUS2 and gpUS11 of human cytomegalovirus incompletely protect infected cells from CD8 T cell recognition.

Besold K, Wills M, Plachter B.

Virology. 2009 Aug 15;391(1):5-19. doi: 10.1016/j.virol.2009.06.004. Epub 2009 Jun 30.

11.

CD8 T cell-evasive functions of human cytomegalovirus display pervasive MHC allele specificity, complementarity, and cooperativity.

Ameres S, Besold K, Plachter B, Moosmann A.

J Immunol. 2014 Jun 15;192(12):5894-905. doi: 10.4049/jimmunol.1302281. Epub 2014 May 7.

12.

Cytomegalovirus encodes a positive regulator of antigen presentation.

Holtappels R, Gillert-Marien D, Thomas D, Podlech J, Deegen P, Herter S, Oehrlein-Karpi SA, Strand D, Wagner M, Reddehase MJ.

J Virol. 2006 Aug;80(15):7613-24.

13.

Immediate-Early (IE) gene regulation of cytomegalovirus: IE1- and pp71-mediated viral strategies against cellular defenses.

Torres L, Tang Q.

Virol Sin. 2014 Dec;29(6):343-52. doi: 10.1007/s12250-014-3532-9. Epub 2014 Nov 25. Review.

14.

Target structures of the CD8(+)-T-cell response to human cytomegalovirus: the 72-kilodalton major immediate-early protein revisited.

Kern F, Surel IP, Faulhaber N, Frömmel C, Schneider-Mergener J, Schönemann C, Reinke P, Volk HD.

J Virol. 1999 Oct;73(10):8179-84.

15.
16.

Human Macrophages Escape Inhibition of Major Histocompatibility Complex-Dependent Antigen Presentation by Cytomegalovirus and Drive Proliferation and Activation of Memory CD4+ and CD8+ T Cells.

Frascaroli G, Lecher C, Varani S, Setz C, van der Merwe J, Brune W, Mertens T.

Front Immunol. 2018 May 25;9:1129. doi: 10.3389/fimmu.2018.01129. eCollection 2018.

17.

Cytomegalovirus interleukin-10 expression in infected cells does not impair MHC class I restricted peptide presentation on bystanding antigen-presenting cells.

Pepperl-Klindworth S, Besold K, Frankenberg N, Farkas M, Kuball J, Theobald M, Plachter B.

Viral Immunol. 2006 Spring;19(1):92-101.

PMID:
16553554
18.

Identification of HLA-A*2402-restricted HCMV immediate early-1 (IE-1) epitopes as targets for CD8+ HCMV-specific cytotoxic T lymphocytes.

Lim JB, Kim HO, Jeong SH, Ha JE, Jang S, Lee SG, Lee K, Stroncek D.

J Transl Med. 2009 Aug 23;7:72. doi: 10.1186/1479-5876-7-72.

19.

Human cytomegalovirus proteins pp65 and immediate early protein 1 are common targets for CD8+ T cell responses in children with congenital or postnatal human cytomegalovirus infection.

Gibson L, Piccinini G, Lilleri D, Revello MG, Wang Z, Markel S, Diamond DJ, Luzuriaga K.

J Immunol. 2004 Feb 15;172(4):2256-64.

20.

Expansion of human cytomegalovirus (HCMV) immediate-early 1-specific CD8+ T cells and control of HCMV replication after allogeneic stem cell transplantation.

Sacre K, Nguyen S, Deback C, Carcelain G, Vernant JP, Leblond V, Autran B, Dhedin N.

J Virol. 2008 Oct;82(20):10143-52. doi: 10.1128/JVI.00688-08. Epub 2008 Aug 6.

Supplemental Content

Support Center